New SARS-CoV-2 lineage has spread across many Brazilian states
Researchers in Brazil have identified the emergence of a new lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Brazil that has spread across multiple states in the country.
The SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) that continues to pose a threat to global public health and the worldwide economy.
Marilda Siqueira from the Oswaldo Cruz Institute (Fiocruz) in Rio de Janeiro and colleagues say this new variant of interest (VOI) probably emerged in August 2020 and is already widely distributed in Brazil.
Designated as N.9, the variant emerged in the B.1.1.33 lineage and comprised 35% of all B.1.1.33 sequences detected between November 2020 and February 2021.
Researchers in the United States have developed “chimeric” vaccines that provided cross-protection against different strains of sarbecovirus in mice, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).
Pulse Oximeter Market Size Worth $3.4 Billion By 2028 | CAGR: 6.4%: Grand View Research, Inc.
SAN FRANCISCO, March 16, 2021 /PRNewswire/ The global pulse oximeter market size is expected
to reach USD 3.4 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 6.4% from 2021 to 2028. Technological advancements in products, growing healthcare costs, and readmission, and increasing adoption of pulse oximetry devices are expected to boost market growth during the forecast period. Market players are introducing devices that are more efficient and support telehealth approaches. For instance, in February 2017, the company received a CE mark for Rad-97 Pulse CO-Oximeter used to monitor blood pressure at set intervals. It is also capable of transferring the data to a remotely connected device.
Researchers from the US recently studied the prevalence of PASC in a well-characterized cohort of patients to gain insights into the period following acute SARS-CoV-2 infection. The research is posted online to the preprint server medRxiv.
Vaccines to foreign countries not at the expense of Indians, says Harsh Vardhan
Updated:
Updated:
A healthy balance is being maintained and WHO criteria being followed: Harsh Vardhan
Share Article
AAA
Union Health Minister Harsh Vardhan speaks in the Rajya Sabha during the Budget session of Parliament, in New Delhi on March 16, 2021.
| Photo Credit:
PTI
A healthy balance is being maintained and WHO criteria being followed: Harsh Vardhan
Union Health Minister Harsh Vardhan told the Rajya Sabha on Tuesday that vaccines to foreign countries are not being sent at the expense of Indian citizens.
“A healthy balance is being maintained. Yesterday [Monday] over 30 lakh people got the vaccines. The criteria has been fixed according to the World Health Organisation and other international standards. It is a dynamic process. Even today among the priority groups if anyone who wants a vaccine can register on COWIN portal and get vaccinated. Vaccine is free in all government hospi